Michael C Stauder
Overview
Explore the profile of Michael C Stauder including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
688
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Outcomes After Breast Radiation Therapy in a Diverse Patient Cohort With a Germline BRCA1/2 Mutation
Chapman B, Liu D, Shen Y, Olamigoke O, Lakomy D, Gutierrez Barrera A, et al.
Int J Radiat Oncol Biol Phys
. 2021 Oct;
112(2):426-436.
PMID: 34610390
Purpose: BRCA1/2 pathogenic variant (PV) mutations confer radiation sensitivity preclinically, but there are limited data regarding breast cancer outcomes after radiation therapy (RT) among patients with documented BRCA1/2 PV mutations...
12.
Chapman B, Liu D, Shen Y, Olamigoke O, Lakomy D, Gutierrez Barrera A, et al.
Int J Radiat Oncol Biol Phys
. 2021 Sep;
112(2):437-444.
PMID: 34582940
Purpose: Multigene panel testing has increased the detection of germline mutations in patients with breast cancer. The implications of using radiation therapy (RT) to treat patients with pathogenic variant (PV)...
13.
Weng J, Lei X, Schlembach P, Bloom E, Shaitelman S, Arzu I, et al.
Int J Radiat Oncol Biol Phys
. 2021 May;
111(2):360-370.
PMID: 33992718
Purpose: There are limited prospective data on predictors of patient-reported outcomes (PROs) after whole-breast irradiation (WBI) plus a boost. We sought to characterize longitudinal PROs and cosmesis in a randomized...
14.
Pasalic D, Strom E, Allen P, Williamson T, Poenisch F, Amos R, et al.
Int J Radiat Oncol Biol Phys
. 2020 Sep;
109(2):441-448.
PMID: 32946965
Purpose: To perform a planned interim analysis of acute (within 12 months) and late (after 12 months) toxicities and cosmetic outcomes after proton accelerated partial breast irradiation (APBI). Methods And...
15.
Corrigan K, Mainwaring W, Miller A, Lin T, Jethanandani A, Espinoza A, et al.
Oncologist
. 2020 Apr;
25(6):e990-e992.
PMID: 32272505
Male breast cancer treatment regimens are often extrapolated from female-based studies because of a paucity of literature analyzing male breast cancer. Using ClinicalTrials.gov, we analyzed breast cancer randomized clinical trials...
16.
Stecklein S, Rosso K, Nuanjing J, Tadros A, Weiss A, DeSnyder S, et al.
Pract Radiat Oncol
. 2019 May;
9(6):402-409.
PMID: 31132433
Purpose: Inflammatory breast cancer (IBC) has been characterized by high locoregional recurrence (LRR) rates even after trimodality therapy. We recently reported excellent locoregional control among patients treated since formal dedication...
17.
Shaitelman S, Lei X, Thompson A, Schlembach P, Bloom E, Arzu I, et al.
J Clin Oncol
. 2018 Nov;
:JCO1800317.
PMID: 30379626
Purpose: The adoption of hypofractionated whole-breast irradiation (HF-WBI) remains low, in part because of concerns regarding its safety when used with a tumor bed boost or in patients who have...
18.
Chance W, Ortiz-Ortiz K, Liao K, Zegarra D, Stauder M, Giordano S, et al.
J Glob Oncol
. 2018 Sep;
4:1-9.
PMID: 30241162
Purpose: To identify rates of postoperative radiation therapy (RT) after breast conservation surgery (BCS) in women with stage I or II invasive breast cancer treated in Puerto Rico and to...
19.
Van Wyhe R, Caudle A, Shaitelman S, Perkins G, Buchholz T, Hoffman K, et al.
Adv Radiat Oncol
. 2018 Sep;
3(3):252-257.
PMID: 30197937
Purpose: Physical examination and diagnostic imaging are often less precise in determining the extent of disease in invasive lobular carcinoma (ILC) relative to nonlobular histologies. Anecdotally, surgical axillary evaluation frequently...
20.
Grossberg A, Lei X, Xu T, Shaitelman S, Hoffman K, Bloom E, et al.
JAMA Oncol
. 2018 Jul;
4(12):1751-1757.
PMID: 30027292
Importance: Whether genetic factors can identify patients at risk for radiation-induced fibrosis remains unconfirmed. Objective: To assess the association between the C-509T variant allele in the promoter region of TGFB1...